Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension

American Journal of Hypertension

Volumn 9, Issue 6, 1996, Pages 523-528

  Yoshihara, Fumiki ^a   Nishikimi, Toshio ^a   Yoshitomi, Yuji ^a   Nakasone, Izuru ^a   Abe, Hitoshi ^a   Matsuoka, Hiroaki ^a   Omae, Teruo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Echocardiography; Essential hypertension; Left ventricular hypertrophy; Primary aldosteronism; Renovascular hypertension

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE RELAXATION; HUMAN; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RENOVASCULAR HYPERTENSION; SYSTOLIC BLOOD PRESSURE;

EID: 0030176030     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00031-3     Document Type: Article

References (38)

1. 1. Messerli FH, Sundgaard-Riise K, Ventura HO, et al: Clinical and hemodynamic determinants of left ventricular dimensions. Arch Intern Med 1984;144:477-481.
2. 2. Suzuki T, Abe H, Nagata S, et al: Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism. Am J Cardiol 1988; 62:1224-1227.
3. 3. Rostrup M, Smith G, Bjornstad H, et al: Left ventricular mass and cardiovascular reactivity in young men. Hypertension 1994;23(suppl I):I-168-I-171.
4. 4. Drayer JIM, Weber MA, Young JLD: BP as a determinant of cardiac left ventricular muscle mass. Arch Intern Med 1983;143:90-92.
5. 5. Devereux RB, Pickering TG, Harshfield GA, et al: Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983;68:470-476.
6. 6. Ferrara LA, Mancini M, Simone GD, et al: Adrenergic nervous system and left ventricular mass in primary hypertension. Eur Heart J 1989;10:1036-1040.
7. 7. Dunn FG, Oigman W, Ruse KS, et al: Racial differences in cardiac adaptation to essential hypertension determined by echocardiographic indexes. J Am Coll Cardiol 1983;5:1348-1351.
8. 8. Brilla CG, Pick R, Tan LB, et al: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-1364.
9. 9. Linz W, Scholkens BA, Ganten D: Converting enzyme inhibitor specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens [A] 1989;11:1325-1350.
10. 10. Duprez DA, Bauwens FR, De Buyzere ML, et al: Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1993;71:17A-20A.
11. 11. Vensel LA, Devereux RB, Pickering TG, et al: Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis. Am J Cardiol 1986;58:575-582.
12. 12. Denolle T, Chatellier G, Julien J, et al: Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. Am J Hypertens 1993;6:907-913.
13. 13. Sahn DJ, DeMaria A, Kisslo J, et al: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
14. 14. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1980;55:613-618.
15. 15. Ganau A, Devereux RB, Roman MJ, et al: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19:1550-1558.
16. 16. Bahler RC, Vrobel TR, Martin P: The relation of heart rate and shortening fraction to echocardiographic indexes of left ventricular relaxation in normal subjects. J Am Coll Cardiol 1983;2:926-933.
17. 17. Snider AR, Gidding SS, Rocchini AP, et al: Doppler evaluation of left ventricular diastolic filling in children with systemic hypertension. Am J Cardiol 1985;56:921-926.
18. 18. Ren JF, Pancholy SB, Iskandrian AS, et al: Doppler echocardiographic evaluation of the spectrum of left ventricular diastolic dysfunction in essential hypertension. Am Heart J 1994;127:906-913.
19. 19. Fouad FM, Slominski JM, Tarazi RC: Left ventricular diastolic function in hypertension; relation to left ventricular mass and systolic function. J Am Coll Cardiol 1984;3:1500-1506.
20. 20. Bonaduce D, Breglio R, Conforti G, et al: Myocardial hypertrophy and left ventricular diastolic function in hypertensive patients: an echo Doppler evaluation. Eur Heart J 1989;10:611-621.
21. 21. Inoue I, Massie B, Loge D, et al: Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1984;53:120-126.
22. 22. Snider AR, Gidding SS, Rocchini AP, et al: Doppler evaluation of left ventricular diastolic filling in children with systemic hypertension. Am J Cardiol 1985;56:921-926.
23. 23. Dianzumba SB, DiPette DJ, Cornman C, et al: Left ventricular filling characteristics in mild untreated hypertension. Hypertension 1986;8(suppl II):II-156-II-160.
24. 24. Verdecchia P, Schillaci G, Guerrieri M, et al: Prevalence and determinants of left ventricular diastolic filling abnormalities in an unselected hypertensive population. Eur Heart J 1990;11:679-691.
25. 25. Licata G, Scaglione R, Parrinello G, et al: Rapid left ventricular filling in untreated hypertensive subjects with or without left ventricular hypertrophy. Chest 1992;102:1507-1511.
26. 26. Amodeo C, Kobrin I, Ventura HO, et al: Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension. Circulation 1986;73(1): 108-113.
27. 27. Dunn FG, Ventura HO, Messerli FH, et al: Time course of regression of left ventricular hypertrophy in hypertensive patients treated with atenolol. Circulation 1987; 76(2):254-258.
28. 28. Fouad-Traazi FM, Liebson PR: Echocardiographic studies of regression of left ventricular hypertrophy in hypertension. Hypertension 1987;9(suppl II):II-65-II-68.
29. 29. Smith VE, White WB, Meeran MK, et al: Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol 1986;8:1449-1454.
30. 30. Grossman E, Oren S, Garavaglia GE, et al: Systemic and regional hemodynamic and humoral effects of nitrendipine in essential hypertension. Circulation 1988; 78:1394-1400.
31. 31. Muiesan ML, Agabiti-Rosei E, Romanelli G, et al: Left ventricular systolic function in relation to withdrawal of different pharmacological treatments in hypertensives with left ventricular hypertrophy. J Hypertens 1988;6(suppl 4):S97-S100.
32. 32. Schulman SP, Weiss JL, Becker LC, et al: The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med 1990;322:1350-1356.
33. 33. Phillips RA, Ardeljan M, Shimabukuro S, et al: Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension. J Am Coll Cardiol 1991;17:1595-1602.
34. 34. Motz W, Strauer BE: Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989;13:43-50.
35. 35. Brilla CG, Janicki JS, Weber KT: Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991;83:1771-1779.
36. 36. Frohlich ED, Sasaki O: Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats. J Am Coll Cardiol 1990;16:1492-1499.
37. 37. Frohlich ED, Horinaka S: Cardiac and aortic effects of angiotensin converting enzyme inhibitors. Hypertension 1991;18(suppl II):II-2-II-7.
38. 38. Frohlich ED, Sasaki O, Chien Y, et al: Changes in cardiovascular mass, left ventricular pumping ability and aortic distensibility after calcium antagonists in Wistar-Kyoto and spontaneously hypertensive rats. J Hypertens 1992;10:1369-1378.